RecruitingNot ApplicableNCT06781515

Assessment of Disease Burden in Hairy Cell Leukemia


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

45 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Drug-free, single-center, prospective observational pilot study in hairy Cell Leukemia patients


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the burden of disease in people with hairy cell leukemia — a rare, slow-growing blood cancer — at different stages: newly diagnosed, in relapse, or in remission. Researchers want to better understand treatment needs and long-term outcomes. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis of hairy cell leukemia - You are newly diagnosed and about to start treatment, OR in relapse needing further therapy, OR in remission for at least 5 years **You may NOT be eligible if...** - You have a second active cancer at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPeripheral and BM blood sample

Peripheral and BM blood samples will be analyzed with the ddPCR method


Locations(1)

IRCCS Azienda Ospedaliero - Universitaria di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06781515


Related Trials